Familial Hemophagocytic Lymphohistiocytosis: A Rare Mutation of STXBP2 in Exon 19

Abstract

Familial hemophagocytic lymphohistiocytosis (FHLH) is a fulminant rapidly progressive disorder characterized by uncontrolled immune system activation. Over the last decade, STXBP2 mutations have been reported as causative. We report a baby with typical clinical features and supportive laboratory findings, who had a homozygous missense variation in exon 19 of STXBP2 that results in an amino acid substitution of aspartic acid for glycine. Adding to the currently scant literature on this variation may contribute to the database pool and help to confirm assertion of pathogenicity in FHLH.

Keywords

hemophagocytic lymphohistiocytosis - STXBP2 - exon 19

• References

• 1 Zhang K, Filipovich AH, Johnson J. , et al. Hemophagocytic Lymphohistiocytosis, Familial. 2006 March 22 [Updated 2013 Jan 17]. In: Adam MP, Ardinger HH, Pagon RA. , et al., eds. GeneReviews^® [Internet]. Seattle, WA: University of Washington; ; 1993–2019. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1444/ . Accessed August 2, 2019
• 2 Henter JI, Horne AC, Arico M. , et al. HLH 2004: diagnostic and therapeutic guidelines for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48 (02) 124-131
• 3 Horne A, Janka G, Maarten Egeler R. , et al; Histiocyte Society. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129 (05) 622-630
• 4 Zhang K, Chandrakasan S, Chapman H. , et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood 2014; 124 (08) 1331-1334
• 5 Meeths M, Entesarian M, Al-Herz W. , et al. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood 2010; 116 (15) 2635-2643
• 6 Pagel J, Beutel K, Lehmberg K. , et al. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood 2012; 119 (25) 6016-6024
• 7 Jain R, Puliyel M, Moses PD, Sieni E. Novel STXBP2 mutation causing familial hemophagocytic lymphohistiocytosis. Indian Pediatr 2012; 49 (06) 488-490
• 8 Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood 2011; 118 (15) 4041-4052
• 9 zur Stadt U, Rohr J, Seifert W. , et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009; 85 (04) 482-492
• 10 Cetica V, Santoro A, Gilmour KC. , et al. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5. J Med Genet 2010; 47 (09) 595-600
• 11 Al Hawas R, Ren Q, Ye S, Karim ZA, Filipovich AH, Whiteheart SW. Munc18b/STXBP2 is required for platelet secretion. Blood 2012; 120 (12) 2493-2500
• 12 Tellam JT, Macaulay SL, McIntosh S, Hewish DR, Ward CW, James DE. Characterization of Munc-18c and syntaxin-4 in 3T3-L1 adipocytes. Putative role in insulin-dependent movement of GLUT-4. J Biol Chem 1997; 272 (10) 6179-6186
• 13 Misura KMH, Scheller RH, Weis WI. Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex. Nature 2000; 404 (6776): 355-362
• 14 Hackmann Y, Graham SC, Ehl S. , et al. Syntaxin binding mechanism and disease-causing mutations in Munc18-2. Proc Natl Acad Sci U S A 2013; 110 (47) E4482-E4491